Combined effects of bee venom acupuncture and morphine on Oxaliplatin-induced neuropathic pain in mice

Woojin Kim, Min Joon Kim, Donghyun Go, Byung Il Min, Heung Sik Na, Sun Kwang Kim

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Oxaliplatin, a chemotherapeutic drug for colorectal cancer, induces severe peripheral neuropathy. Bee venom acupuncture (BVA) has been used to attenuate pain, and its effect is known to be mediated by spinal noradrenergic and serotonergic receptors. Morphine is a well-known opioid used to treat different types of pain. Here, we investigated whether treatment with a combination of these two agents has an additive effect on oxaliplatin-induced neuropathic pain in mice. To assess cold and mechanical allodynia, acetone and von Frey filament tests were used, respectively. Significant allodynia signs were observed three days after an oxaliplatin injection (6 mg/kg, i.p.). BVA (0.25, 1, and 2.5 mg/kg, s.c., ST36) or morphine (0.5, 2, and 5 mg/kg, i.p.) alone showed dose-dependent anti-allodynic effects. The combination of BVA and morphine at intermediate doses showed a greater and longer effect than either BVA or morphine alone at the highest dose. Intrathecal pretreatment with the opioidergic (naloxone, 20 μg) or 5-HT3 (MDL-72222, 15 μg) receptor antagonist, but not with α2-adrenergic (idazoxan, 10 μg) receptor antagonist, blocked this additive effect. Therefore, we suggest that the combination effect of BVA and morphine is mediated by spinal opioidergic and 5-HT3 receptors and this combination has a robust and enduring analgesic action against oxaliplatin-induced neuropathic pain.

Original languageEnglish
JournalToxins
Volume8
Issue number2
DOIs
Publication statusPublished - 2016 Jan 22

Fingerprint

oxaliplatin
Acupuncture
Bee Venoms
Neuralgia
Morphine
Hyperalgesia
Idazoxan
Receptors, Serotonin, 5-HT3
Pain
Peripheral Nervous System Diseases
Naloxone
Acetone
Adrenergic Agents
Opioid Analgesics
Analgesics
Colorectal Neoplasms
Injections

Keywords

  • Bee venom acupuncture
  • Chemotherapy induced neuropathic pain
  • Morphine
  • Oxaliplatin

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Combined effects of bee venom acupuncture and morphine on Oxaliplatin-induced neuropathic pain in mice. / Kim, Woojin; Kim, Min Joon; Go, Donghyun; Min, Byung Il; Na, Heung Sik; Kim, Sun Kwang.

In: Toxins, Vol. 8, No. 2, 22.01.2016.

Research output: Contribution to journalArticle

Kim, Woojin ; Kim, Min Joon ; Go, Donghyun ; Min, Byung Il ; Na, Heung Sik ; Kim, Sun Kwang. / Combined effects of bee venom acupuncture and morphine on Oxaliplatin-induced neuropathic pain in mice. In: Toxins. 2016 ; Vol. 8, No. 2.
@article{322f9ccc01d94015bd2b2b8d4ef7b217,
title = "Combined effects of bee venom acupuncture and morphine on Oxaliplatin-induced neuropathic pain in mice",
abstract = "Oxaliplatin, a chemotherapeutic drug for colorectal cancer, induces severe peripheral neuropathy. Bee venom acupuncture (BVA) has been used to attenuate pain, and its effect is known to be mediated by spinal noradrenergic and serotonergic receptors. Morphine is a well-known opioid used to treat different types of pain. Here, we investigated whether treatment with a combination of these two agents has an additive effect on oxaliplatin-induced neuropathic pain in mice. To assess cold and mechanical allodynia, acetone and von Frey filament tests were used, respectively. Significant allodynia signs were observed three days after an oxaliplatin injection (6 mg/kg, i.p.). BVA (0.25, 1, and 2.5 mg/kg, s.c., ST36) or morphine (0.5, 2, and 5 mg/kg, i.p.) alone showed dose-dependent anti-allodynic effects. The combination of BVA and morphine at intermediate doses showed a greater and longer effect than either BVA or morphine alone at the highest dose. Intrathecal pretreatment with the opioidergic (naloxone, 20 μg) or 5-HT3 (MDL-72222, 15 μg) receptor antagonist, but not with α2-adrenergic (idazoxan, 10 μg) receptor antagonist, blocked this additive effect. Therefore, we suggest that the combination effect of BVA and morphine is mediated by spinal opioidergic and 5-HT3 receptors and this combination has a robust and enduring analgesic action against oxaliplatin-induced neuropathic pain.",
keywords = "Bee venom acupuncture, Chemotherapy induced neuropathic pain, Morphine, Oxaliplatin",
author = "Woojin Kim and Kim, {Min Joon} and Donghyun Go and Min, {Byung Il} and Na, {Heung Sik} and Kim, {Sun Kwang}",
year = "2016",
month = "1",
day = "22",
doi = "10.3390/toxins8020033",
language = "English",
volume = "8",
journal = "Toxins",
issn = "2072-6651",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "2",

}

TY - JOUR

T1 - Combined effects of bee venom acupuncture and morphine on Oxaliplatin-induced neuropathic pain in mice

AU - Kim, Woojin

AU - Kim, Min Joon

AU - Go, Donghyun

AU - Min, Byung Il

AU - Na, Heung Sik

AU - Kim, Sun Kwang

PY - 2016/1/22

Y1 - 2016/1/22

N2 - Oxaliplatin, a chemotherapeutic drug for colorectal cancer, induces severe peripheral neuropathy. Bee venom acupuncture (BVA) has been used to attenuate pain, and its effect is known to be mediated by spinal noradrenergic and serotonergic receptors. Morphine is a well-known opioid used to treat different types of pain. Here, we investigated whether treatment with a combination of these two agents has an additive effect on oxaliplatin-induced neuropathic pain in mice. To assess cold and mechanical allodynia, acetone and von Frey filament tests were used, respectively. Significant allodynia signs were observed three days after an oxaliplatin injection (6 mg/kg, i.p.). BVA (0.25, 1, and 2.5 mg/kg, s.c., ST36) or morphine (0.5, 2, and 5 mg/kg, i.p.) alone showed dose-dependent anti-allodynic effects. The combination of BVA and morphine at intermediate doses showed a greater and longer effect than either BVA or morphine alone at the highest dose. Intrathecal pretreatment with the opioidergic (naloxone, 20 μg) or 5-HT3 (MDL-72222, 15 μg) receptor antagonist, but not with α2-adrenergic (idazoxan, 10 μg) receptor antagonist, blocked this additive effect. Therefore, we suggest that the combination effect of BVA and morphine is mediated by spinal opioidergic and 5-HT3 receptors and this combination has a robust and enduring analgesic action against oxaliplatin-induced neuropathic pain.

AB - Oxaliplatin, a chemotherapeutic drug for colorectal cancer, induces severe peripheral neuropathy. Bee venom acupuncture (BVA) has been used to attenuate pain, and its effect is known to be mediated by spinal noradrenergic and serotonergic receptors. Morphine is a well-known opioid used to treat different types of pain. Here, we investigated whether treatment with a combination of these two agents has an additive effect on oxaliplatin-induced neuropathic pain in mice. To assess cold and mechanical allodynia, acetone and von Frey filament tests were used, respectively. Significant allodynia signs were observed three days after an oxaliplatin injection (6 mg/kg, i.p.). BVA (0.25, 1, and 2.5 mg/kg, s.c., ST36) or morphine (0.5, 2, and 5 mg/kg, i.p.) alone showed dose-dependent anti-allodynic effects. The combination of BVA and morphine at intermediate doses showed a greater and longer effect than either BVA or morphine alone at the highest dose. Intrathecal pretreatment with the opioidergic (naloxone, 20 μg) or 5-HT3 (MDL-72222, 15 μg) receptor antagonist, but not with α2-adrenergic (idazoxan, 10 μg) receptor antagonist, blocked this additive effect. Therefore, we suggest that the combination effect of BVA and morphine is mediated by spinal opioidergic and 5-HT3 receptors and this combination has a robust and enduring analgesic action against oxaliplatin-induced neuropathic pain.

KW - Bee venom acupuncture

KW - Chemotherapy induced neuropathic pain

KW - Morphine

KW - Oxaliplatin

UR - http://www.scopus.com/inward/record.url?scp=84957556326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957556326&partnerID=8YFLogxK

U2 - 10.3390/toxins8020033

DO - 10.3390/toxins8020033

M3 - Article

C2 - 26805884

AN - SCOPUS:84957556326

VL - 8

JO - Toxins

JF - Toxins

SN - 2072-6651

IS - 2

ER -